Hoechst Aktiengesellschaft

Bimal N Ganguli

Hans-Wolfram Fehlhaber

Herbert Kogler

Erra K Vijayakumar

Sugata Chatterjee

Christopher M Franco

Jurgen Blumbach

Richard H Rupp

Triptikumar Mukhopadhyay

Kirity Roy

Goukanapalli C Reddy

Werner Aretz

Suresh R Nadkarni

Julia Gandhi

Mahesh V Patel

Kalvanapuram R Desikan

Volker Teetz

Hans-Harald Sedlacek

Laszlo Vertesy

Gerhard Seibert

Noel J De Souza

Hans P Kraemer

Matthias Helsberg

Michael Limbert

Hans G Berscheid

Gerhard Huber

Dipak K Chatterjee

Joachim Betz

Laslo Vertesy

Dieter-Andreas Sukatsch

Balbir S Bajwa, Deceased

Jurgen Reden

Gauknapalli C Reddy

Ratan S Sood

Deepak K Chatterjee

Rajendra K Jani

Sukumar Chatterjee

Louis E Coutinho

Dilip J Upadhyay

Ravi G Bhat

Ramaiyer R Chandran

Balhimycin, a compound of the molecular formula C.sub.66 H.sub.73 C1.sub.2 N.sub.9 0.sub.24, is a novel Glycopeptide antibiotic and has the following structure: ##STR1##

Antibiotic, balhimycin, a process for its production and its use as

Salmycins, a process for their preparation and their use as a pharmaceutical Compounds of formula I, ##STR1## wherein R denotes .dbd.NOH (a), .dbd.O (b); --OH and --H (c), --NH.sub.2 and --H (d) or .dbd.N--O--R'(e);

Salmycins, a process for their preparation and their use as a

Compounds 31668P and 31668U, a process for their production and their use. Compound 31668P and compound 31668U with the formulae ##STR1## have an antibiotic and an antitumor action.

Compounds 31668P and 31668U, a process for their production and their use

Balhimycin, a compound of the molecular formula C.sub.66 H.sub.73 Cl.sub.2 N.sub.9 O.sub.24, is a novel Glycopeptide antibiotic and has the following structure (SEQ. ID. No. 1): ##STR1##

Deoxymulundocandin, a compound of the formula I (SEQ. ID NO: 1) ##STR1## has an antiyeast, an antifungal and an immunomodulatory action.

Antibiotic, deoxymulundocandin, a process for its production and its use

Cammunocin, an active substance which can be obtained by cultivation of Streptomyces species Y-84,36210 (DSM 4329), has antibiotic and immunosuppressant activity.

Antibiotic, cammunocin, a process for the preparation thereof, and the

The novel compounds of formulas I and II ##STR1## have an antibiotic activity.

Antibiotic compounds and their production

Aranorosinol-A and Aranorosinol-B are compounds of the formula ##STR1## in which R is H (Aranorosinol-A) or CH.sub.2 COCH.sub.3 (Aranorosinol-B); said compounds have antibacterial and antifungal activity.

Aranorosinol-A and aranorosinol-B produced by Pseudoarachniotus roseus

Butalactin, a compound of the formula I ##STR1## can be produced by cultivation of Streptomyces species Y-86,36923. Butalactin has an antibiotic activity.

Butalactin and its use as pharmaceutical

Alisamycin, a compound of the formula I ##STR1## has an antibiotic, antitumor and antiparasitic action.

Antibiotic alisamycin and its use

A new antibiotic, aranorosin, a microbiological process for the preparation thereof, and the use thereof as a pharmaceutical. Aranorosin, a compound of the formula ##STR1## can be prepared with the aid of the fungus culture Y-30499 (DSM 4151). Aranorosin has an antibiotic action as well as an action against malignant tumors.

Antibiotic, aranorosin, a microbiological process for the preparation

Mersacidin, a cyclic peptide of the formula I ##STR1## has antibiotic activity.

Antibiotic, mersacidin, a process for the preparation thereof and the

Fumifungin, a compound of the formula ##STR1## can be isolated from the culture broth of fungus culture No. Y-83,0405 (DSM 4152), and has bactericidal and fungicidal properties.

Antibiotic, fumifungin, a microbial process for the preparation thereof,

The present invention relates to the macrolide antibiotic swalpamycin, to a microbiological process for its preparation, to a new microorganism strain Streptomyces species, and to the use of swalpamycin as a medicinal agent for the treatment of infections caused by bacteria, mycoplasmas and Actinomycetes.

Macrolide antibiotic and its use as a medicinal agent

The present invention relates to the compound naphthomycin H of the formula I ##STR1## and to a microbiological process for its preparation. The compound is active against Gram-positive bacteria and fungi and can be used as an antibiotic.

Growing community of inventors

Bombay, India

Bimal N Ganguli